A mobile health program to help youth with HIV manage depression and stick to their treatment.
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
['FUNDING_OTHER'] · WASHINGTON UNIVERSITY · NIH-10950383
This study is testing a helpful mobile app called Suubi-mhealth that supports Ugandan teens aged 14-17 living with HIV and feeling down, by offering friendly digital therapy to improve their mental health and help them stick to their treatment.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | WASHINGTON UNIVERSITY (nih funded) |
| Locations | 1 site (SAINT LOUIS, UNITED STATES) |
| Trial ID | NIH-10950383 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a mobile health intervention called Suubi-mhealth aimed at supporting Ugandan youth aged 14-17 who are living with HIV and experiencing depression. The program will provide digital therapy through a mobile application, incorporating cognitive-behavioral therapy techniques tailored to the cultural and developmental needs of these young individuals. By addressing both mental health and adherence to antiretroviral therapy (ART), the intervention seeks to improve overall health outcomes for this vulnerable population. The approach is designed to be accessible and engaging, helping youth navigate their treatment journey more effectively.
Who could benefit from this research
Good fit: Ideal candidates for this research are Ugandan youth aged 14-17 who are living with HIV and experiencing symptoms of depression.
Not a fit: Patients who are not living with HIV or who do not experience depression may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve mental health and treatment adherence among youth living with HIV in Uganda.
How similar studies have performed: Previous research has shown that mobile health interventions can be effective in improving mental health and treatment adherence, suggesting a promising avenue for this approach.
Where this research is happening
SAINT LOUIS, UNITED STATES
- WASHINGTON UNIVERSITY — SAINT LOUIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: NABUNYA, PROSCOVIA — WASHINGTON UNIVERSITY
- Study coordinator: NABUNYA, PROSCOVIA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus